1409 in Re Cyclobenzaprine Hydrochloride Extended- Release Capsule Patent Litigation… v. MYLAN PHARMACEUTICALS INC. and MYLAN INC.

United States Court of Appeals
for the Federal Circuit
______________________
May 1, 2012
ERRATA
______________________
Appeal Nos. 2011-1399, -1409
IN RE CYCLOBENZAPRINE HYDROCHLORIDE EXTENDED-
RELEASE CAPSULE PATENT LITIGATION
---------------------------------------------------------------------------------
EURAND, INC., CEPHALON, INC., and ANESTA AG,
Plaintiffs-Cross Appellants,
v.
MYLAN PHARMACEUTICALS INC. and MYLAN INC.,
Defendants-Appellants,
and
BARR LABORATORIES, INC., TEVA PHARMACEUTICALS USA,
INC., and TEVA PHARMACEUTICAL INDUSTRIES LTD.,
Defendants-Appellees.
______________________
Decided: April 16, 2012
Precedential Opinion
______________________
Please make the following additions:
Page 2, Of counsel on the brief for plaintiff-cross appellant was Tryn T.
Stimart, Cooley Godward Kronish LLP, of Washington, DC.
Robert L. Byer, Duane Morris LLP, of Pittsburg, Pennsylvania, for
amici curiae Gregory Dolin and Robert C. Kahrl. With him on the
brief were Kristina Caggiano and Elese Hanson.

-- 1 of 1 --